Cernapex, Inc. is an early stage systems biology company focused on novel therapeutics targeted to the peroxisome and peroxisomal function.  We leverage state of the art development methods leveraging the latest proetemic and genetic technolologies to identify targeted solutions for cancer, metabolic dysfunction and rare genetic disorders.

We are actively seeking parners for research and development opportunities.